I'm with you POS. After the positive Rett results I never thought this SP territory would be revisited. There isn't even a bad trial result to cause it to drop it back nearly 50%. Plus there are 3 further top line results in 2nd half 2015.
The churning of these converted options is creating some brilliant buying opportunities leading up to the next run of results.
Ann: Annual Report to shareholders, page-25
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.47 |
Change
0.080(0.41%) |
Mkt cap ! $2.486B | |||
| Open | High | Low | Value | Volume |
| $19.58 | $19.85 | $19.23 | $9.536M | 488.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 773 | $19.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.70 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 10/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.51 |
Change
0.080 ( 0.62 %) |
||||
| Open | High | Low | Volume | ||
| $19.60 | $19.82 | $19.24 | 217738 | ||
| Last updated 15.59pm 10/06/2024 ? | |||||
| NEU (ASX) Chart |